> 5-Amino-1MQ 50 mg · Lumera Labs
For laboratory research use only. Not for human consumption. Free cold-chain shipping over $70 CAD · Ships from Kelowna, BC
Free cold-chain shipping over $200 CAD · Ships from Kelowna, BC
Home / Catalog / Metabolic / 5-Amino-1MQ 50 mg
5-Amino-1MQ 50 mg vial
4.7 · 118 researcher reviews
Longevity · Small-molecule NNMT inhibitor

5-Amino-1MQ

SKU LUM-5A1MQ-50 · C₁₀H₁₂N₂ · 160.22 g/mol · CAS 57052-10-7

A selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Studied for sirtuin and methionine-cycle pharmacology.

Purity (HPLC)
≥ 99.1%
Net peptide
5.00 mg ± 2%
Endotoxin
< 0.5 EU/mg
Format
Lyophilized vial
Storage
−20 °C, desiccated
Shelf life
24 months from MFG
$70CAD / 50 mg vial
In stock · Lot 26-A031
Qty
Bulk 10+: $24 / vial
Add $200 for free cold-chain shipping
  • HPLC + MS verified per lot
  • Cold-chain to your door
  • COA bundled with shipment
  • Lot retains kept 5 years

Overview

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule selective inhibitor of nicotinamide N-methyltransferase (NNMT), the enzyme that consumes SAM and nicotinamide to produce 1-methylnicotinamide. NNMT inhibition raises cellular nicotinamide and SAM, indirectly modulating sirtuin substrate availability and methylation potential.

Lumera supplies 5-Amino-1MQ as a lyophilized powder for in-vitro biochemistry use. Vials are sealed under nitrogen and shipped cold-chain at −20 °C from our Kelowna facility.

Research applications

NNMT enzymatic inhibition assays, cellular SAM/methylation balance studies, sirtuin substrate-availability investigations, and adipocyte energy-expenditure models.

Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.

Identity

ParameterValue
Sequence5-amino-1-methylquinolinium (small-molecule heterocycle)
Molecular formulaC₁₀H₁₂N₂
Molecular weight160.22 g/mol
CAS number57052-10-7
LengthSmall molecule (not a peptide)

Quality

TestSpecification
HPLC purity≥ 99.0% (lot LM-2657: 99.42%)
Mass confirmationESI-MS within 0.5 Da
Net peptide content≥ 80% by AAA
Endotoxin< 0.5 EU/mg (LAL)
Bioburden< 10 CFU/g
Residual TFA< 1.0%

Lot LM-2657

Manufactured 04 Mar 2026 · Released 11 Mar 2026 · Tested by Lumera QC, Kelowna BC. Retain samples held under storage spec for five years from release date.

Verification

MethodResult
RP-HPLC at 220 nm99.42% main peak
ESI-MS (positive)160.2 Da (theor. 160.22)
Amino acid analysis82.1% net peptide
LAL endotoxin< 0.05 EU/mg
Karl Fischer (water)2.8% w/w

Reconstitution

Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0–2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.

Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.

Storage after reconstitution

Reconstituted solution is stable for 28 days at 2–8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.

Selected references

Kannt A et al. A small molecule inhibitor of nicotinamide N-methyltransferase. J Med Chem. 2016;59(20):9390–9402.

Neelakantan H et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase. Biochem Pharmacol. 2017;133:103–115.

Pissios P. Nicotinamide N-methyltransferase: more than a vitamin B3 clearance enzyme. Trends Endocrinol Metab. 2017;28(5):340–353.

Citing this material

5-Amino-1MQ reference standard, ≥99% (HPLC), Lumera Labs Inc., Cat. No. LUM-5A1MQ-50, Lot 26-A031.

Related · Longevity axis

Often paired in studies.

View catalog

Why Lumera

  • Janoshik Analytical HPLC ≥ 99.1% on this lot
  • LC-MS identity confirmed before release
  • LAL endotoxin below detection limit
  • Cold-chain shipped −20°C from Kelowna, BC
$70 CAD